Research Article
Ocular Manifestations of Biopsy-Proven Pulmonary Sarcoidosis in Korea
Table 1
Clinical features of patients with biopsy-proven pulmonary sarcoidosis according to ocular involvement.
| | Ocular involvement () | No ocular involvement () | value |
| Mean age | 57.1 ± 15.5 | 48.0 ± 13.7 | 0.045 | Female/male ratio | 35/4 | 10/6 | 0.048 | BHL in radiography | 34 (87.2%) | 15 (93.8%) | 0.66 | Increased ACE | 29 (74.4%) | 8 (50.0%) | 0.12 | ACE level | 77.1 ± 40.9 | 61.7 ± 33.9 | 0.19 | Visual acuity at last visit | 0.83 ± 0.19 | 0.90 ± 0.14 | 0.15 | Systemic treatment | 28 (71.8%) | 5 (31.3%) | 0.007 | Immunosuppression | 14 (35.9%) | 0 (0.0%) | 0.005 |
|
|
aBilateral hilar lymphadenopathy; bangiotensin-converting enzyme.
|